Synthesis and Molecular Docking Analysis of New Thiazo-isoindolinedione Hybrids as Potential Inhibitors of the SARS-CoV-2 Main Protease

被引：2

作者：

Shaaban, Saad ^{[1
,2
]}

Al-Karmalawy, Ahmed A. ^{[3
]}

Alhamzani, Abdulrahman G. ^{[4
]}

Abou-Krisha, Mortaga M. ^{[4
,5
]}

Al-Qudah, Mahmoud A. ^{[4
,6
]}

Yousef, Tarek A. ^{[4
,7
]}

机构：

[1] King Faisal Univ, Dept Chem, Coll Sci, Al Hasa 31982, Saudi Arabia

[2] Mansoura Univ, Dept Chem, Fac Sci, Mansoura 35516, Egypt

[3] Ahram Canadian Univ, Dept, Fac Pharm, Giza 12566, Egypt

[4] Imam Mohammad Ibn Saud Islam Univ, Dept Chem, Coll Sci, Riyadh 11623, Saudi Arabia

[5] Yarmouk Univ, Dept Chem, Fac Sci, POB 566, Irbid 21163, Jordan

[6] South Valley Univ, Dept Chem, Qena 83523, Egypt

[7] Minist Justice, Dept Toxic & Narcot Drug, Forens Med, Medicolegal Org,Mansoura Lab, Cairo, Egypt

来源：

ORIENTAL JOURNAL OF CHEMISTRY | 2023年 / 39卷 / 04期

关键词：

Condensation; COVID-19; Isoindolinedione; Thiazolidinedione; Molecular docking;

D O I：

10.13005/ojc/390412

中图分类号：

Q5 [生物化学]; Q7 [分子生物学];

学科分类号：

071010 ; 081704 ;

摘要：

Herein, we report the synthesis of novel thiazo-isoindolinedione derivatives in excellent yields (up to 92%) from the reaction of thiazolidinedione and isoindoline-dione. The structures of the novel compounds were elucidated by H-1-, C-13-NMR, and MS analyses. Furthermore, molecular docking analysis was performed to study the potential inhibition of the SARS-CoV-2 main protease (M-pro) by the new thiazo-isoindolinediones. The present study revealed that the new thiazo-isoindolinediones could inhibit the Mpro and represent a promising platform for the experimental development of new antiviral drugs based on thiazo-isoindolinedione scaffolds.

引用

页码：913 / 918

页数：6

共 50 条

[1] Molecular Docking Unveils Prospective Inhibitors for the SARS-COV-2 Main Protease
Ahmad, Fawad
Ikram, Saima
Ahmad, Jamshaid
Rehman, Irshad Ur
Khattak, Saeed Ullah
Butt, Sadia
Mushtaq, Maryam
SAINS MALAYSIANA, 2021, 50 (05): : 1473 - 1484
[2] Comparative molecular investigation of the potential inhibitors against SARS-CoV-2 main protease: a molecular docking study
Khan, Md Arif
Mahmud, Shafi
Ul Alam, A. S. M. Rubayet
Rahman, Md Ekhtiar
Ahmed, Firoz
Rahmatullah, Mohammed
JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS, 2021, 39 (16): : 6317 - 6323
[3] Screening of potential inhibitors targeting the main protease structure of SARS-CoV-2 via molecular docking
Yang, Xinbo
Xing, Xianrong
Liu, Yirui
Zheng, Yuanjie
FRONTIERS IN PHARMACOLOGY, 2022, 13
[4] An investigation into the identification of potential inhibitors of SARS-CoV-2 main protease using molecular docking study
Das, Sourav
Sarmah, Sharat
Lyndem, Sona
Singha Roy, Atanu
JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS, 2021, 39 (09): : 3347 - 3357
[5] Potential SARS-CoV-2 main protease inhibitors
Banerjee, Riddhidev
Perera, Lalith
Tillekeratne, L. M. Viranga
DRUG DISCOVERY TODAY, 2021, 26 (03) : 804 - 816
[6] Computational Docking Study of Calanolides as Potential Inhibitors of SARS-CoV-2 Main Protease
Benalia, Abdelkrim
Abdeldjebar, Hasnia
Badji, Taqiy Eddine
FRENCH-UKRAINIAN JOURNAL OF CHEMISTRY, 2022, 10 (01): : 48 - 59
[7] Molecular dynamics simulation of docking structures of SARS-CoV-2 main protease and HIV protease inhibitors
Cardoso, Wesley B.
Mendanha, Sebastiao A.
JOURNAL OF MOLECULAR STRUCTURE, 2021, 1225
[8] Potential bioactive glycosylated flavonoids as SARS-CoV-2 main protease inhibitors: A molecular docking and simulation studies
Cherrak, Sabri Ahmed
Merzouk, Hafida
Mokhtari-Soulimane, Nassima
PLOS ONE, 2020, 15 (10):
[9] A molecular docking study of potential inhibitors and repurposed drugs against SARS-CoV-2 main protease enzyme
Ercan, Selami
Cinar, Ercan
JOURNAL OF THE INDIAN CHEMICAL SOCIETY, 2021, 98 (03)
[10] Repurposing of known anti-virals as potential inhibitors for SARS-CoV-2 main protease using molecular docking analysis
Hakmi, Mohammed
Bouricha, El Mehdi
Kandoussi, Ilham
El Harti, Jaouad
Ibrahimi, Azeddine
BIOINFORMATION, 2020, 16 (04) : 301 - 305

← 1 2 3 4 5 →